207_Combined course Presentations

Why 45 Gy BID failed to adopt ?

 Inconvenience of twice daily treatment

 Increased rate of esophagitis

 Suboptimal control arm in “Turrisi” trial

 Lack of phase III trial comparing hyperfractionation with “high-dose” conventionally fractionated treatment